CLINICAL_TRIALS
trial_result
· 2017-05-15
Clinical Trial Update: Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis [Phase 1]
Summary
Phase 1 trial evaluating immunity conferred by immunization with cryopreserved Plasmodium falciparum sporozoites under chloroquine prophylaxis; the study has co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanaria Inc. | Conditions: Malaria, Plasmodium Falciparum | Phase 1 | Status: COMPLETED